Vasopressin inhibition by lithium.
D000818:Animals; D001714:Bipolar Disorder / Q000188:drug therapy; D003919:Diabetes Insipidus / Q000139:chemically induced; D005260:Female; D006801:Humans; D007671:Kidney Concentrating Ability / Q000187:drug effects; D008094:Lithium / Q000009:adverse effects* / Q000494:pharmacology; D008875:Middle Aged; D051381:Rats; D014667:Vasopressins / Q000037:antagonists & inhibitors*
D014667:Vasopressins; D008094:Lithium